158 related articles for article (PubMed ID: 28676291)
1. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents.
Zullo AR; Dore DD; Gutman R; Mor V; Alvarez CA; Smith RJ
J Am Med Dir Assoc; 2017 Oct; 18(10):879-884.e7. PubMed ID: 28676291
[TBL] [Abstract][Full Text] [Related]
2. Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.
Lee SJ; Stijacic-Cenzer I; Barnhart C; McClymont K; Steinman MA
J Am Med Dir Assoc; 2015 Oct; 16(10):898.e9-14. PubMed ID: 26272298
[TBL] [Abstract][Full Text] [Related]
3. National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010.
Zullo AR; Dore DD; Daiello L; Baier RR; Gutman R; Gifford DR; Smith RJ
J Am Med Dir Assoc; 2016 Jul; 17(7):602-8. PubMed ID: 27052559
[TBL] [Abstract][Full Text] [Related]
4. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate Fentanyl Prescribing Among Nursing Home Residents in the United States.
Fain KM; Castillo-Salgado C; Dore DD; Segal JB; Zullo AR; Alexander GC
J Am Med Dir Assoc; 2017 Feb; 18(2):138-144. PubMed ID: 27720662
[TBL] [Abstract][Full Text] [Related]
6. Fingerstick Glucose Monitoring in Veterans Affairs Nursing Home Residents with Diabetes Mellitus.
Jeon SY; Shi Y; Lee AK; Hunt L; Lipska K; Boscardin J; Lee S
J Am Geriatr Soc; 2021 Feb; 69(2):424-431. PubMed ID: 33064879
[TBL] [Abstract][Full Text] [Related]
7. Adoption of sodium-glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents.
Hayes KN; Berry SD; Munshi MN; Zullo AR
J Am Geriatr Soc; 2023 Aug; 71(8):2585-2592. PubMed ID: 37078149
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus.
Lapane KL; Jesdale BM; Dubé CE; Pimentel CB; Rajpathak SN
Diabetes Res Clin Pract; 2015 Aug; 109(2):411-9. PubMed ID: 26008723
[TBL] [Abstract][Full Text] [Related]
9. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
Roumie CL; Min JY; D'Agostino McGowan L; Presley C; Grijalva CG; Hackstadt AJ; Hung AM; Greevy RA; Elasy T; Griffin MR
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28424149
[TBL] [Abstract][Full Text] [Related]
10. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
Desai NR; Shrank WH; Fischer MA; Avorn J; Liberman JN; Schneeweiss S; Pakes J; Brennan TA; Choudhry NK
Am J Med; 2012 Mar; 125(3):302.e1-7. PubMed ID: 22340932
[TBL] [Abstract][Full Text] [Related]
11. Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study.
Zullo AR; Lee Y; Daiello LA; Mor V; John Boscardin W; Dore DD; Miao Y; Fung KZ; Komaiko KDR; Steinman MA
J Am Geriatr Soc; 2017 Apr; 65(4):754-762. PubMed ID: 27861719
[TBL] [Abstract][Full Text] [Related]
12. Frequency and Predictors of Analgesic Prescribing in U.S. Nursing Home Residents with Persistent Pain.
Fain KM; Alexander GC; Dore DD; Segal JB; Zullo AR; Castillo-Salgado C
J Am Geriatr Soc; 2017 Feb; 65(2):286-293. PubMed ID: 28198563
[TBL] [Abstract][Full Text] [Related]
13. Comparative safety of sulfonylureas among U.S. nursing home residents.
Zullo AR; Riester MR; Hayes KN; Munshi MN; Berry SD
J Am Geriatr Soc; 2023 Apr; 71(4):1047-1057. PubMed ID: 36495141
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety of dipeptidyl peptidase-4 inhibitors and sulfonylureas among frail older adults.
Zullo AR; Smith RJ; Gutman R; Kohler B; Duprey MS; Berry SD; Munshi MN; Dore DD
J Am Geriatr Soc; 2021 Oct; 69(10):2923-2930. PubMed ID: 34291453
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.
Asche CV; McAdam-Marx C; Shane-McWhorter L; Sheng X; Plauschinat CA
Drugs Aging; 2008; 25(7):611-22. PubMed ID: 18582148
[TBL] [Abstract][Full Text] [Related]
16. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
17. Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.
Zullo AR; Sharmin S; Lee Y; Daiello LA; Shah NR; John Boscardin W; Dore DD; Lee SJ; Steinman MA
J Am Geriatr Soc; 2017 Nov; 65(11):2397-2404. PubMed ID: 29044457
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort Study.
Weeda ER; Ward R; Gebregziabher M; Chandler O; Strychalski ML; Axon RN; Taber DJ
Prim Care Diabetes; 2023 Aug; 17(4):386-391. PubMed ID: 37121788
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy.
Calabrese AT; Coley KC; DaPos SV; Swanson D; Rao RH
Arch Intern Med; 2002 Feb; 162(4):434-7. PubMed ID: 11863476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
